6 Feb 2026
Synthesis of 4-chloro-N′-(2-cyanoacetyl)benzohydrazide derivatives, cytotoxicity, VEGFR-2/EGFRT790M bioassays and in silico docking/ADMET studiesPublisher siteBioorganic Chemistry, Synthesis and biological activity
Active, last published 2026
In synthesis and biological activity
Mo’men
Salem
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Arish University
Egypt
Claim Your ProfileEgypt4
H-index
50
Citations
Mo’men has not officially claimed their profile. If you are Mo’men, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
o’men Salem is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mo’men's work has been cited 50 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×8Synthesis and Biological Evaluation×5Cancer therapeutics and mechanisms×4Click Chemistry and Applications×2
04 · Where I am
Affiliations
Affiliation on published researchSinai University, EgyptDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
7 works3 Feb 2026
Benzimidazole-derived VEGFR-2 inhibitors: Docking, ADMET, anticancer evaluations, design and synthesisPublisher siteJournal of Molecular Structure, Angiogenesis and VEGF in Cancer
28 Oct 20252cites
Chitosan/polyacrylic acid nanogel-mediated delivery system for cancer treatment: Design, synthesis, ADMET, docking of thiazole derivatives as dual inhibitors of VEGFR-2 and EGFRT790MPublisher siteBioorganic Chemistry, Nanoparticle-Based Drug Delivery
5 Jun 202516cites
Discovery of novel thiazolopyrimidine derivatives targeting topoisomerase II: Design, synthesis, antiproliferative evaluation, molecular docking and apoptosis inducing activityPublisher siteBioorganic Chemistry, Cancer therapeutics and mechanisms
1 Jun 2025
Nano-carrier for [1,2,4]triazolo[4,3-a]quinoxaline derivatives as inhibitors of Topo-II and intercalators for DNA: Design, synthesis, in silico docking, ADMET and anti-proliferative evaluationsPublisher siteJournal of Molecular Structure, Synthesis and Biological Evaluation
11 Apr 20252cites
Nano-carrier, design, synthesis, in silico ADMET, anti-proliferative assessments and docking of [1,2,4]triazolo[4,3-a]quinoxalines as Topo-II inhibitors and DNA intercalatorsPublisher siteNaunyn-Schmiedeberg s Archives of Pharmacology, Synthesis and Biological Evaluation
1 Jan 2025Open access10cites
A two-decade overview of oxadiazole derivatives as promising anticancer agentsPublisher siteRSC Advances, Synthesis and biological activity
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mo’men?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you